Search PubMedSearch

PubMed · 1069181

[Percutaneous chordotomy].

Abstract

The authors review 134 cases of percutaneous cervical chordotomy in 95 patients; 86 patients suffered from malignant tumors, while the pain was caused by benign growths in only 9 cases. The immediate postoperative findings are compared with the clinical results of the follow-up medical examination. Chronological and numerical data follow on permanent sucesses and recurrence rates. The author's own morbidity and mortality rates are contrasted with those if other authors, and compared with the risk involved in open chordotomy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W Grote, C W Roosen. 1976-11-15. [Percutaneous chordotomy].. https://doi.org/10.1007/bf01267354

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Acute morphine dependence in mice selectively-bred for high and low analgesia.

Acute morphine dependence was compared in mice selectively-bred for high (HA) and low (LA) swim stress-induced analgesia and high (HAR) and low (LAR) levorphanol analgesia by counting the number of naloxone-precipitated jumps. Whereas LAR mice displayed greater acute morphine dependence than HAR mice, HA and LA mice did not differ. No genotypic differences were observed in non-dependent mice, discounting possible differences in basal naloxone sensitivity and/or opioid peptide levels. Thus, the two selection projects, while both producing lines exhibiting highly divergent sensitivity to morphine analgesia, have not had analogous effects on all opioid measures, supporting the notion of independent genetic mediation of opioid analgesia and dependence. Further, these data suggest that analgesic sensitivity may not predict sensitivity to morphine dependence.

Analgesia

An analgesia circuit activated by cannabinoids.

Although many anecdotal reports indicate that marijuana and its active constituent, delta-9-tetrahydrocannabinol (delta-9-THC), may reduce pain sensation, studies of humans have produced inconsistent results. In animal studies, the apparent pain-suppressing effects of delta-9-THC and other cannabinoid drugs are confounded by motor deficits. Here we show that a brainstem circuit that contributes to the pain-suppressing effects of morphine is also required for the analgesic effects of cannabinoids. Inactivation of the rostral ventromedial medulla (RVM) prevents the analgesia but not the motor deficits produced by systemically administered cannabinoids. Furthermore, cannabinoids produce analgesia by modulating RVM neuronal activity in a manner similar to, but pharmacologically dissociable from, that of morphine. We also show that endogenous cannabinoids tonically regulate pain thresholds in part through the modulation of RVM neuronal activity. These results show that analgesia produced by cannabinoids and opioids involves similar brainstem circuitry and that cannabinoids are indeed centrally acting analgesics with a new mechanism of action.

Analgesia